The known complexity of the HLA system continues to grow. Simultaneously, investigators are constructing a molecular model for the human major histocompatibility complex that accounts for the extensive variation at the HLA loci. Three alleles were given new WHO nomenclature at the HLA-A locus, 7 at HLA-B, 7 at HLA-D, and 6 at HLA-DR. Two entirely new loci were given WHO status: HLA-DQ and HLA-DP. The HLA-A, -B, and -C loci (class I genes) code for a polypeptide chain containing cytoplasmic, transmembrane, and extracellular regions. In turn the extracellular region can be divided into three domains. The molecular organization of the class 1 gene is discussed. The class I1 genes in the HLA-D/DR complex can be grouped into three regions, DR, DC, and SB, with one WHO-defined locus associated with each: HLA-DR, HLA-DQ, and HLA-DP, respectively. Class I1 molecules have both an alpha-and a beta-chain, which can be divided into cytoplasmic, transmembrane, and extracellular regions. The extracellular region of both polypeptide chains has two domains. The molecular organization of the alpha-and beta-chain genes is discussed. Serological polymorphism for both the class I and I1 molecules has been located in the domains most distal to the cellular membrane. The domain closest to the membrane in both alpha-and beta-chains of class I1 molecules is conserved and exhibits homology with one another and with the constant regions of IgG molecules and with beta-2-microglobulin. Therefore, it is likely that the genes of the major histocompatibility complex have evolved from a primordial gene which has differentiated into at least four related families: HLA class I, HLA class 11, IgG immunoglobulin heavy and light chains, and beta-2-microglobulin, When discussing the major histocompatibility complex (HLA), arguably the most polymorphic and extensive human genetic system yet defined, one is confronted with a large array of baming nomenclature and, with the emergence of the new molecular model, with concepts that at first glance appear to have no relation. In an earlier review, the basic serology, genetics, population genetics, and applications of the HLA system were described (Williams, 1982). The present review presents the 1984 WHO (World Health Organization) nomenclature that resulted from the 9th International HLA Workshop, an introduction to the new HLA-DP and HLA-DQ loci, and a brief discussion of the molecular model that is emerging for the human histocompatibility complex.The IXth International HLA Workshop, which was held in Munich, West Germany, in May 1984, revealed two major trends, one familiar, one new (Albert et al., 1984). As in the many workshops of previous years, the HLA system grew in complexity and refinement. Many new alleles were added to the major loci while 0 1985 Alan R. Liss, Inc.